Published in Catheter Cardiovasc Interv on August 01, 1999
Yes reflow. Catheter Cardiovasc Interv (1999) 0.75
Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med (1999) 6.93
Access to coronary artery bypass surgery by race/ethnicity and gender among patients who are appropriate for surgery. Med Care (1999) 3.07
Clinical success, complications and restenosis rates with excimer laser coronary angioplasty. The Percutaneous Excimer Laser Coronary Angioplasty Registry. Am J Cardiol (1992) 2.08
Cardiac motion of coronary arteries: variability in the rest period and implications for coronary MR angiography. Radiology (1999) 1.88
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation (1999) 1.82
Percutaneous laser thermal angioplasty: initial clinical results with a laser probe in total peripheral artery occlusions. Lancet (1986) 1.72
[A case of chronic pulmonary hypertension after fenfluramine intake]. Wien Klin Wochenschr (1982) 1.72
Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells. J Clin Invest (1997) 1.69
Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol (2000) 1.66
Expanded indications for laser-assisted balloon angioplasty in peripheral arterial disease. J Vasc Surg (1990) 1.62
Structural studies on phophatidylcholine-cholesterol mixed vesicles. Biochemistry (1975) 1.52
Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling. Cell Death Differ (2013) 1.49
Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury. Am J Pathol (1995) 1.49
Percutaneous endocardial transfer and expression of genes to the myocardium utilizing fluoroscopic guidance. Catheter Cardiovasc Interv (2001) 1.44
The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy. Br J Radiol (2014) 1.41
Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation (2000) 1.39
Regulation of human interleukin-2 and interferon-gamma gene expression by suppressor T lymphocytes. Scand J Immunol (1991) 1.39
"Clinical PET: its time has come?". J Nucl Med (1993) 1.39
Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg (1998) 1.37
Angiopeptin inhibits intimal hyperplasia after angioplasty in porcine coronary arteries. Circulation (1993) 1.34
Current questions for the treatment of advanced gastric cancer. Cancer Treat Rev (2012) 1.27
Tumour stem cell-targeted treatment: elimination or differentiation. Ann Oncol (2006) 1.25
Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152. Oncogene (2007) 1.23
The Lugano statements on controlled clinical trials. J Int Med Res (1987) 1.23
Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels. Lancet (2000) 1.22
Control of Drosophila head segment identity by the bZIP homeotic gene cnc. Development (1995) 1.19
Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1. J Clin Invest (1995) 1.18
Reactions of cobalt(I) supernucleophiles. The alkylation of vitamin B12s cobaloximes(I), and related compounds. J Am Chem Soc (1969) 1.15
Coronary MR angiography: selection of acquisition window of minimal cardiac motion with electrocardiography-triggered navigator cardiac motion prescanning--initial results. Radiology (2001) 1.14
Dietary and hormonal regulation of hepatic biosynthetic and catabolic enzymes of serine metabolism in rats. Endocrinology (1972) 1.12
Macrophage and foam cell release of matrix-bound growth factors. Role of plasminogen activation. J Biol Chem (1993) 1.11
Biodistribution of Tc-99m methoxy-isobutyl-isonitrile (MIBI) in humans. Eur J Nucl Med (1989) 1.10
Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave Roussy. Ann Oncol (2007) 1.09
The history of interventional cardiology: cardiac catheterization, angioplasty, and related interventions. Am Heart J (1995) 1.09
Elevated Egr-1 in human atherosclerotic cells transcriptionally represses the transforming growth factor-beta type II receptor. J Biol Chem (2000) 1.08
Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators. N Engl J Med (1995) 1.06
Experimental angioplasty: circumferential distribution of laser thermal energy with a laser probe. J Am Coll Cardiol (1985) 1.06
Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor. J Cell Physiol (1993) 1.06
Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety. Ann Oncol (2011) 1.04
Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. A possible role for antioxidants in restenosis. Circulation (1993) 1.03
Human percutaneous and intraoperative laser thermal angioplasty: initial clinical results as an adjunct to balloon angioplasty. J Vasc Surg (1987) 1.02
Preparative methods for brain slices: a discussion. J Neurosci Methods (1995) 1.01
Spontaneous spinal epidural hematoma with spinal cord compression complicating plasma cell myeloma. A case report. Spine (Phila Pa 1976) (1998) 1.01
Platelet accumulation in experimental angioplasty: time course and relation to vascular injury. Circulation (1987) 1.00
Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry. Am Heart J (2001) 1.00
Angiographic and histologic consequences of laser thermal angioplasty: comparison with balloon angioplasty. Circulation (1987) 0.99
The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine. Int J Rad Appl Instrum B (1986) 0.99
Letter: Reverse transcriptase in plasma of patients with breast cancer. Lancet (1974) 0.98
Diffusion of radiotracers in normal and ischemic brain slices. J Cereb Blood Flow Metab (1998) 0.98
The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance. J Mol Cell Cardiol (1999) 0.98
Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121. Ann Thorac Surg (2000) 0.97
Percutaneous coronary laser thermal angioplasty. J Am Coll Cardiol (1986) 0.97
A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trial. J Am Coll Cardiol (2001) 0.96
Transforming growth factor-beta receptor types I and II are expressed in renal tubules and are increased after chronic unilateral ureteral obstruction. Life Sci (1998) 0.96
The nucleophilicity of vitamin B12. J Am Chem Soc (1968) 0.95
Laser angioplasty for limb salvage: observations on early results. J Vasc Surg (1989) 0.95
Total recall of radiotherapy with mTOR inhibitors: a novel and potentially frequent side-effect? Ann Oncol (2011) 0.94
Enhancement of radiation response by inhibition of Aurora-A kinase using siRNA or a selective Aurora kinase inhibitor PHA680632 in p53-deficient cancer cells. Br J Cancer (2007) 0.93
Transluminal angioplasty in experimental atherosclerosis. Analysis for embolization using an in vivo perfusion system. Circulation (1982) 0.93
Reduction in angioplasty complications after the introduction of coronary stents: results from a consecutive series of 2242 patients. Am Heart J (1996) 0.93
Specific inhibition of eIF-5A and collagen hydroxylation by a single agent. Antiproliferative and fibrosuppressive effects on smooth muscle cells from human coronary arteries. J Clin Invest (1995) 0.93
Serum sialyltransferase levels as a parameter in the diagnosis and follow-up of gastrointestinal tumors. Cancer Res (1980) 0.92
Childhood obesity prevention studies: lessons learned and to be learned. Public Health Nutr (2006) 0.91
Effect of antiplatelet therapy on restenosis after experimental angioplasty. Am J Cardiol (1984) 0.91
Carcinosarcoma of the nose and paranasal sinuses-a case report. Rhinology (1982) 0.91
T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates. Thromb Haemost (1983) 0.90
Benzo[a]pyrene induces the transcription of cyclooxygenase-2 in vascular smooth muscle cells. Evidence for the involvement of extracellular signal-regulated kinase and NF-kappaB. J Biol Chem (2000) 0.90
Caspase independence of radio-induced cell death. Oncogene (2006) 0.89
Coronary artery perforation during excimer laser coronary angioplasty. The percutaneous Excimer Laser Coronary Angioplasty Registry. J Am Coll Cardiol (1993) 0.89
Decreased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irradiation. Br J Cancer (2000) 0.89
Normal tissues toxicities triggered by combined anti-angiogenic and radiation therapies: hurdles might be ahead. Br J Cancer (2012) 0.89
Cationic [99mTcIII(DIARS)2(SR)2]+ complexes as potential myocardial perfusion imaging agents (DIARS = o-phenylenebis(dimethylarsine);SR- = thiolate). J Med Chem (1996) 0.89
Cooperative effect of roscovitine and irradiation targets angiogenesis and induces vascular destabilization in human breast carcinoma. Cell Prolif (2009) 0.89
Restenosis following transluminal angioplasty in experimental atherosclerosis. Arteriosclerosis (1984) 0.89
Investigation of the medium-term effects of Olibratrade mark fat emulsion on food intake in non-obese subjects. Eur J Clin Nutr (2006) 0.88
Lymphoid papillary hyperplasia of the palatine tonsils. Am J Surg Pathol (1983) 0.88
Chronic unilateral ureteral obstruction is associated with interstitial fibrosis and tubular expression of transforming growth factor-beta. Lab Invest (1996) 0.88
Fluid-attenuated inversion recovery and diffusion- and perfusion-weighted MRI abnormalities in 117 consecutive patients with stroke symptoms. Stroke (2001) 0.87
Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma. Oncogene (2003) 0.87
DnrD cyclase involved in the biosynthesis of doxorubicin: purification and characterization of the recombinant enzyme. Biochemistry (1999) 0.87
Pheochromocytoma of the heart. Am J Cardiol (2000) 0.86
Phase I dose-escalating study of ES-285 given as a three-hour intravenous infusion every three weeks in patients with advanced malignant solid tumors. Invest New Drugs (2012) 0.86
[Causal therapeutic management of aplastic anaemia (author's transl)]. Wien Klin Wochenschr (1981) 0.86
[The effect of raubasine on the vein tonus and venous capacity of the lower leg]. Z Kreislaufforsch (1968) 0.86
Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells. Br J Cancer (2001) 0.86
Radiation-induced expression of functional Fas ligand in EBV-positive human nasopharyngeal carcinoma cells. Int J Cancer (2000) 0.85
Independent effects of estradiol on water and food intake. Behav Neurosci (1983) 0.85
Early limitations of coronary excimer laser angioplasty. J Am Coll Cardiol (1991) 0.85
External fixation using microplates after laryngotracheal expansion surgery. An animal study. Arch Otolaryngol Head Neck Surg (1991) 0.84
Increased danger of bone marrow damage in simultaneous azathioprine-allopurinol therapy. Int J Clin Pharmacol Ther Toxicol (1981) 0.84
n-3 polyunsaturated fatty acids decrease mucosal/epidermal reactions and enhance antitumour effect of ionising radiation with inhibition of tumour angiogenesis. Br J Cancer (2003) 0.84
[A simple method for the preparation of human factor VII-deficient plasma]. Thromb Diath Haemorrh (1967) 0.84
99mTc(L-L)3+ complexes containing ether analogs of DMPE. Nucl Med Biol (1999) 0.83
Acute otitis media in the first two months of life: characteristics and diagnostic difficulties. Arch Dis Child (2008) 0.83
Effects of calcium ions on glucose utilization in the rat suprachiasmatic nucleus in vitro. Brain Res (1987) 0.83